Ramipril inhibits AGE-RAGE-induced matrix metalloproteinase-2 activation in experimental diabetic nephropathy

被引：0
|
作者：
Kei Fukami
Sho-ichi Yamagishi
Melinda T Coughlan
Brooke E Harcourt
Phillip Kantharidis
Vicki Thallas-Bonke
Seiya Okuda
Mark E Cooper
Josephine M Forbes
机构：
[1] Kurume University School of Medicine,Division of Nephrology, Department of Medicine
[2] Kurume University School of Medicine,Department of Pathophysiology and Therapeutics of Diabetic Vascular Complications
[3] Baker IDI Heart and Diabetes Institute,Diabetes Division
[4] Monash University,Department of Medicine, Central Clinical School
[5] Mater Medical Research Institute,Department of Glycation and Diabetic Complications
来源：
Diabetology & Metabolic Syndrome | / 6卷
关键词：
Advanced glycation end products; Diabetic nephropathy; Renin-angiotensin system; MMP-2; RAGE; NF-κB;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [41] Chlorotoxin inhibits glioma cell invasion via matrix metalloproteinase-2
    Deshane, J
    Garner, CC
    Sontheimer, H
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2003, 278 (06) : 4135 - 4144
  • [42] Caveolin-1 inhibits matrix metalloproteinase-2 activity in the heart
    Chow, A. K.
    Cena, J.
    El-Yazbi, A. F.
    Crawford, B. D.
    Holt, A.
    Cho, W. J.
    Daniel, E. E.
    Schulz, R.
    JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY, 2007, 42 (04) : 896 - 901
  • [43] Apolactoferrin inhibits the catalytic domain of matrix metalloproteinase-2 by zinc chelation
    Newsome, Anthony L.
    Johnson, Jon Paul
    Seipelt, Rebecca L.
    Thompson, Michael W.
    BIOCHEMISTRY AND CELL BIOLOGY, 2007, 85 (05) : 563 - 572
  • [44] Glucosamine inhibits extracellular matrix accumulation in experimental diabetic nephropathy
    Teuma, Loic
    Eshwaran, Rachana
    Fongang, Ulrich Tawokam
    Wieland, Johanna
    Shao, Feng
    Lagana, Maria Luisa
    Wang, Yixin
    Agaci, Ane
    Hammes, Hans-Peter
    Feng, Yuxi
    FRONTIERS IN NUTRITION, 2022, 9
  • [45] Oroxylin A inhibits matrix metalloproteinase-2/9 expression and activation by up-regulating tissue inhibitor of metalloproteinase-2 and suppressing the ERK1/2 signaling pathway
    Lu, Zhijian
    Lu, Na
    Li, Chenglin
    Li, Fanni
    Zhao, Kai
    Lin, Biqi
    Guo, Qinglong
    TOXICOLOGY LETTERS, 2012, 209 (03) : 211 - 220
  • [46] Erythropoietin Modulates Imbalance of Matrix Metalloproteinase-2 and Tissue Inhibitor of Metalloproteinase-2 in Doxorubicin-induced Cardiotoxicity
    Chen, Xing
    Guo, Zhihua
    Wang, Peixian
    Xu, Miqing
    HEART LUNG AND CIRCULATION, 2014, 23 (08): : 772 - 777
  • [47] ALTERED EXPRESSION OF MATRIX METALLOPROTEINASE-2 TIMP, AND TIMP-2 IN OBSTRUCTIVE NEPHROPATHY
    SHARMA, AK
    MAUER, SM
    KIM, YK
    MICHAEL, AF
    JOURNAL OF LABORATORY AND CLINICAL MEDICINE, 1995, 125 (06): : 754 - 761
  • [48] Activation of Peroxisome Proliferator-Activated Receptor δ Inhibits Angiotensin II-Induced Activation of Matrix Metalloproteinase-2 in Vascular Smooth Muscle Cells
    Ham, Sun Ah
    Lee, Hanna
    Hwang, Jung Seok
    Kang, Eun Sil
    Yoo, Taesik
    Paek, Kyung Shin
    Do, Jeong Tae
    Park, Chankyu
    Oh, Jae-Wook
    Kim, Jin-Hoi
    Han, Chang Woo
    Seo, Han Geuk
    JOURNAL OF VASCULAR RESEARCH, 2014, 51 (03) : 221 - 230
  • [49] The role of matrix metalloproteinase-2 and matrix metalloproteinase-9 in antibody-induced arthritis
    Itoh, T
    Matsuda, H
    Tanioka, M
    Kuwabara, K
    Itohara, S
    Suzuki, R
    JOURNAL OF IMMUNOLOGY, 2002, 169 (05): : 2643 - 2647
  • [50] Novel Role of Mitochondrial Matrix Metalloproteinase-2 in the Development of Diabetic Retinopathy
    Mohammad, Ghulam
    Kowluru, Renu A.
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2011, 52 (06) : 3832 - 3841
12345